SCHEMBL30756402

SCHEMBL30756402

COCCc1cc(Cl)ncn1

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ENPP1 P22413 2/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 1/20 0.33
LDHA P00338 1/20 0.32
HTT P42858 2/20 0.31
HSD17B10 Q99714 1/20 0.31
LMNA P02545 1/20 0.31
FLT1 P17948 2/20 0.31
KDR P35968 2/20 0.31
KDM1A O60341 2/20 0.31
FGFR1 P11362 1/20 0.30
NPC1 O15118 2/20 0.30
RAB9A P51151 2/20 0.30
HCAR2 Q8TDS4 1/20 0.30
MAPK1 P28482 1/20 0.30
HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL274345 0.80 S1PR4 (0.37) ENPP1SMN1; SMN2ALDH1A1LMNANPC1
SCHEMBL16033555 0.78 KDM4E (0.42) ENPP1KDM4EALDH1A1LMNANPC1
SCHEMBL31493066 0.77 HCAR2 (0.37) SMN1; SMN2LDHAHTTLMNAFLT1
SCHEMBL31658834 0.76 DUT (0.31)
SCHEMBL15057849 0.74 GABRA2 (0.38) ENPP1KDM4EALDH1A1LMNA
SCHEMBL15891880 0.74 RECQL (0.36)
SCHEMBL374261 0.74 HRH1 (0.38)
SCHEMBL31658855 0.74 RECQL (0.36)
SCHEMBL13316484 0.73 ALDH1A1 (0.38) SMN1; SMN2ALDH1A1FLT1KDRKDM1A
SCHEMBL1444830 0.73 KCNH2 (0.41) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4554938-A1 TYROSINE KINASE 2 INHIBITORS AND USES THEREOF Biogen MA Inc. (US) 2025-05-21 EP disclosed
CN-119894879-A Tyrosine kinase 2 inhibitors and uses thereof 渤健马萨诸塞州股份有限公司 2025-04-25 CN disclosed
WO-2024015497-A1 TYROSINE KINASE 2 INHIBITORS AND USES THEREOF BIOGEN MA INC. (US) 2024-01-18 WO disclosed